中文 | English
Return
Total: 1479 , 1/148
Show Home Prev Next End page: GO
Author:( Mei JIA)

2.Establishment and application of the critical value monitoring platform

Zhihong YUE ; Mei JIA

Chinese Journal of Laboratory Medicine 2016;(1):7-9

3.Lipoprotein-associated phospholipase A2 and coronary heart disease

Tongge ZHANG ; Mei JIA

Chinese Journal of Laboratory Medicine 2015;(7):493-497

4.To establish a method for detecting genetic polymorphism of CYP2C9 1075A > C and VKORC1-1639 G > A and evaluate the correlation of SNP with Warfarin dose

Lei ZHAO ; Mei JIA

Chinese Journal of Laboratory Medicine 2012;(11):1010-1015

5.Interpretation of the third universal definition of myocardial infarction

Meiyan LIU ; Mei JIA

Chinese Journal of Laboratory Medicine 2013;(6):485-488

6.Diagnostic significance of γ-glutamyl transpeptidase in infants cholestasis of different causes

Qianru JIA ; Mei SUN

Chinese Pediatric Emergency Medicine 2021;28(5):420-423

7.The in vitro HAART pharmacodynamics study with dolutegravir as the "anchor".

Jia-mei GUO ; Ying GUO

Acta Pharmaceutica Sinica 2015;50(1):50-58

8. Study on the different biological characteristics of a multi-drug resistant nasopharyngeal carcinoma cell line CNE2/DDP and its parental cell line CNE2

Jia-Zhuan MEI

Tumor 2007;27(9):706-709

10.Correlation between lipoprotein-associated phospholipase A2 activity and it's gene polymorphism in coronary heart disease

Shanshan LI ; Yue YIN ; Mei JIA

Chinese Journal of Laboratory Medicine 2012;35(10):899-904

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1479 , 1/148 Show Home Prev Next End page: GO